XML 42 R34.htm IDEA: XBRL DOCUMENT v3.25.3
Nature of Business (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Dec. 13, 2024
Jul. 22, 2024
Jul. 28, 2023
Sep. 03, 2020
Aug. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2021
Mar. 31, 2023
Nature of Business                  
Option fee         $ 150,000        
Option additional fee   $ 25,000              
Cash consideration transferrred     $ 8,000            
Operating expenses     $ 2,400     $ 5,628 $ 12,951    
Equity investment in cash                 $ 5,000
Preferred stock, par value (in dollars per share)           $ 0 $ 0    
Cash commission of gross proceeds of sales of common stock, percentage       3.00%          
Proceeds from stock purchase agreement           $ 0 $ 5,000    
Common stock issued or sold under the ATM Offering             0    
Public float       $ 75,000          
Net Income (Loss)           (3,057) (5,263)    
Accumulated deficit           (267,492) (264,417)    
Issuance of common stock             $ 1,953    
Cyclerion                  
Nature of Business                  
Up front payment received $ 1,750         1,250      
Additional up front payment           500      
Akebia                  
Nature of Business                  
Additional milestone cash payment           $ 558,500      
Up front payment received               $ 3,000  
Series A Convertible Preferred Stock                  
Nature of Business                  
Preferred stock, shares issued                 351,037
Preferred stock, par value (in dollars per share)                 $ 8.68
Common Stock                  
Nature of Business                  
Common stock shares issued                 225,000
Issuance of common stock equity private placement and ATM (in shares)             225,000    
ATM Offering | Maximum | Jefferies LLC                  
Nature of Business                  
Issuance of common stock       $ 50,000          
Tisento Therapeutics Holdings Inc                  
Nature of Business                  
Outstanding equity securities     10.00%